Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
GSK-3β in mouse fibroblasts controls wound healing and fibrosis through an endothelin-1–dependent mechanism
Mohit Kapoor, … , David J. Abraham, Andrew Leask
Mohit Kapoor, … , David J. Abraham, Andrew Leask
Published September 18, 2008
Citation Information: J Clin Invest. 2008;118(10):3279-3290. https://doi.org/10.1172/JCI35381.
View: Text | PDF | Retraction
Research Article Dermatology

GSK-3β in mouse fibroblasts controls wound healing and fibrosis through an endothelin-1–dependent mechanism

  • Text
  • PDF
Abstract

Glycogen synthase kinase–3 (GSK-3) is a widely expressed and highly conserved serine/threonine protein kinase encoded by 2 genes, GSK3A and GSK3B. GSK-3 is thought to be involved in tissue repair and fibrogenesis, but its role in these processes is currently unknown. To investigate the function of GSK-3β in fibroblasts, we generated mice harboring a fibroblast-specific deletion of Gsk3b and evaluated their wound-healing and fibrogenic responses. We have shown that Gsk3b-conditional-KO mice (Gsk3b-CKO mice) exhibited accelerated wound closure, increased fibrogenesis, and excessive scarring compared with control mice. In addition, Gsk3b-CKO mice showed elevated collagen production, decreased cell apoptosis, elevated levels of profibrotic α-SMA, and increased myofibroblast formation during wound healing. In cultured Gsk3b-CKO fibroblasts, adhesion, spreading, migration, and contraction were enhanced. Both Gsk3b-CKO mice and fibroblasts showed elevated expression and production of endothelin-1 (ET-1) compared with control mice and cells. Antagonizing ET-1 reversed the phenotype of Gsk3b-CKO fibroblasts and mice. Thus, GSK-3β appears to control the progression of wound healing and fibrosis by modulating ET-1 levels. These results suggest that targeting the GSK-3β pathway or ET-1 may be of benefit in controlling tissue repair and fibrogenic responses in vivo.

Authors

Mohit Kapoor, Shangxi Liu, Xu Shi-wen, Kun Huh, Matthew McCann, Christopher P. Denton, James R. Woodgett, David J. Abraham, Andrew Leask

×

Figure 3

Conditional deletion of Gsk3b in fibroblasts results in elevated collagen, α-SMA production, and fibroblast proliferation and decreased apoptosis in vivo.

Options: View larger image (or click on image) Download as PowerPoint
Conditional deletion of Gsk3b in fibroblasts results in elevated collage...
(A) Wound collagen synthesis. Hydroxyproline levels (a marker of collagen synthesis) were assessed in day 7 wounds. Significantly (P < 0.05) higher levels of hydroxyproline were detected in day 7 wounds of Gsk3b-CKO mice compared with Gsk3b-C mice (n = 6 animals per group). (B) α-SMA protein expression. Western blot analysis showed a significant (P < 0.05) increase in the protein expression of α-SMA in day 7 wounds of Gsk3b-CKO compared with Gsk3b-C mice. Representative data from n = 4 animals per group are shown. (C) α-SMA staining. Immunofluorescence for α-SMA in day 7 wound sections showed a significant (P < 0.05) increase in the number of α-SMA–positive cells in Gsk3b-CKO compared with Gsk3b-C mice (n = 6 animals per group). Arrows indicate α-SMA–positive staining. Scale bar: 100 μm. (D) PCNA staining. Immunohistochemistry for PCNA in day 7 wound sections showed a significant (P < 0.05) increase in the number of PCNA-positive cells in Gsk3b-CKO compared with Gsk3b-C mice (n = 4 animals per group). Arrows indicate PCNA-positive staining. Scale bar: 100 μm. (E) Apoptosis assay in day 7 wound sections showed a significant (P < 0.05) decrease in the number of apoptotic cells in Gsk3b-CKO compared with Gsk3b-C mice (n = 4 animals per group). Arrows indicate apoptotic cells. Scale bar: 100 μm. *P < 0.05.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts